We isolated canine prolactin cDNA from a dog pituitary cDNA library. The 930-bp nucleotide sequence covered the entire open reading frame encoding the putative 229 amino acids. It was located in chromosome 35, and had five exons. The amino acid sequence was highly homologous to the feline and porcine sequences. To generate recombinant canine prolactin, plasmids for full-length canine prolactin were constructed and transfected into the mammalian HEK293 cell line. The recombinant prolactin was secreted into the medium as an N-linked glycosylated (31 kDa) or non-glycosylated (27 kDa) protein. Western blotting revealed both of these bands were canine pituitary protein extracts.
Mammary tumors are the most common neoplasia, and constitute about half of all tumors in female dogs [4-6, 13, 14, 17] . Furthermore, half of all canine mammary tumors ultimately become malignant [7, 15] . Among many factors that predispose to mammary tumors, prolactin (PRL) was first recognized as a hormone that significantly contributed to both the pathogenesis and progression of rodent mammary neoplasia [18] .
PRL is a protein hormone secreted from the anterior pituitary gland and has been identified in many vertebrates. PRL is involved in many biological activities, including reproduction, behavior, growth and development, immunity and metabolism [8] . In particular, PRL plays an important role in mammary gland development as PRL-knockout mice show no lobuloalveolar development [3] . In dogs, PRL is highly secreted during lactation and contributes to mammogenesis in the advanced stages of mammary development, and elevated PRL levels are a risk factor for mammary tumors [11] . However, to our knowledge, no studies have identified the canine PRL gene, although several predicted sequences of canine PRL are reported in the Genbank database (http://www.ncbi.nlm.nih.gov/Genbank/).
In this study, the full-length cDNA clone encoding canine PRL was isolated from a canine pituitary cDNA library, and the expression of the recombinant protein was examined. All experiments were conducted according to the Guidelines for the Care and Use of Laboratory Animals, School of Veterinary Medicine, Kitasato University, Japan. An adult female beagle dog was used. Her pituitary was harvested and total RNA was isolated using a RNA isolation kit (RNeasy Mini Kit, Qiagen, -Note-Germantown, MA, USA). The RNA sample was sent to Hitachi High Technology Corp. (Tokyo, Japan) to produce a high-quality full-length cDNA library using the vector-capping method [10] . A total of 400 clones of the canine pituitary cDNA library in pGCAP10 plasmids were established and sequenced from this sample.
When we first searched for the canine prolactin gene sequence in our cDNA library and compared our findings with the Genbank database, two clones containing the same cDNA sequence (HM369390) were detected. HM369390 is similar to a predicted canine PRL gene (accession No. XM_545363) and a putative canine PRL gene (accession No. AY741405). When the signal peptide of the deduced amino acid sequence of HM369390 was predicted using SignalP [16] (http://www.cbs.dtu. dk/services/SignalP/), the 930-bp nucleotide sequence covered the entire open reading frame encoding a putative 229 amino acid polypeptides (Fig. 1) . The amino acid sequence of HM369390 contains 30 hydrophobic amino acids at its NH2 terminus, which is predicted to be a signal peptide, and has one theoretical N-glycosylation site. The deduced amino acid sequence of HM369390 is 86.10% homologous with XM_545363 and 56.07% homologous with AY741405. The gene for HM369390 also shows high amino acid homology with the gene in other animal species, including the feline and porcine genes (Table 1) .
When the sequences were analyzed by the Basic Local Alignment Search Tool (BLAST, http://blast.ncbi.nlm. nih.gov/) to determine their genomic organization, HM369390 was localized to canine chromosome 35, and found to contain five exons and four introns (Fig. 1) . Although the sequence AY741405 was not detected in the canine chromosome, XM_545363 was identified in the same chromosome, containing six exons and five introns. XM_545363 shares exons II to V with HM369390. PRL in other species has several splicing and/or translational variants. For example, the human PRL gene is composed of six exons, while the translated sequence is composed of five exons [2] . Rat PRL has several biochemical variants because of post translational modification of the peptide, including glycosylation, phosphorylation and cleavage [1] . We found that part of the shared sequences in exon 2 comprised the signal sequence, suggesting that HM369390 and XM_545363 are splicing variants. However, XM_545363 was not detected in our cDNA library. Further studies are needed to clarify the mechanisms that regulate the transcription of the canine PRL gene. Overall, we believe that at least one variant of the canine PRL gene and peptide sequence was detected in this study.
Next, to generate recombinant canine PRL, the plasmids for PRL were constructed. The full-length coding region of canine PRL was amplified by PCR using cDNA (HM369390) as a template. PCR amplification using high-fidelity polymerase (Expand HiFi, Roche Diagnostics, Indianapolis, IN, USA) was performed under standard conditions for 30 cycles of denaturation at 95°C for 15 s, annealing at 60°C for 30 s, polymerization at 72°C for 1 min, and a final polymerization step at 72°C for 10 min. The primers for canine PRL were 5'-GCC GAA TTC ATC GCC ACC ATG GAT AAC AAA-5' and 5'-TAG GGA TCC TTA GCA GTT GCT GTC GTA GAC-3'. The PCR product was sub-cloned into the EcoRI and BamHI sites of pcDNA3.1(-). The DNA sequence of the plasmids was confi rmed with an ABI PRISM 3730 Genetic Analyzer using a Dye Deoxy Terminator Cycle Sequencing Kit (Applied Biosystems, Foster City, CA, USA). The HM369390 expression vector (pcPRL) was transfected into human embryonic kidney (HEK) 293 cells (RIKEN Cell Bank, Tsukuba, Japan). These cells were maintained in DMEM/F12 (Invitrogen, Carlsbad, CA, USA) supplemented with 10% heat-inactivated fetal bovine serum, 100 U/ml penicillin and 100 µg/ml streptomycin (growth medium). Cells were seeded in 24-well plates at a density of 3 × 10 5 cells/well, and transfected with pcPRL using FuGene6 transfection reagent (Roche Diagnostics, Indianapolis, IN, USA). Twenty-four hours after transfection, the culture media were replaced with serum-free media (200 µl/well) and the cells were cultured for 4 days. The conditioned media precipitated by acetone were subjected to western blot analysis as previously described [9] using anti-human PRL antibody (Clone No. C-17, Santa Cruz Biotechnology, Santa Cruz, CA, USA). As shown in Fig. 2A , two signals migrating to a position corresponding to 27 and 31 kDa were detected under reducing conditions. We hypothesized that the recombinant canine PRL was glycosylated in the HEK293 cells. Glycosylated PRL is reported to be an asparagine N-linked oligosaccharide at a single consensus sequence at positions 31-33 on the polypeptide chain [12] . This site of glycosylation has been confirmed in several species [19] , and was identified in canine PRL in this study.
To determine whether the 31-kDa band of canine PRL is the N-glycosylated form, we treated the conditioned media with PNGase F (New England Biolabs, County Road Ipswich, MA, USA). Treatment with PNGase F caused the loss of the 31-kDa band and increased the intensity of the 27-kDa band (Fig. 2B) . These results indicate that the 31-kDa band of canine PRL is the Nglycosylated protein. Glycosylation of PRL is thought to modify its receptor-binding potency and/or its plasma half-life [19] ; however, little is known about the physiological regulation and function of glycosylated PRL. Finally, to confirm whether the recombinant canine PRL protein and native PRL are comparable, we performed western blotting using the conditioned medium of cells transfected pcPRL and the pituitary extract from another adult female dog prepared as previously described [9] . The signal bands for the dog pituitary extract migrated to 27 and 31 kDa, as did the recombinant canine PRL protein (Fig. 2C) . These results indicate that canine PRL is natively secreted as N-glycosylated (31 kDa) and non-glycosylated (27 kDa) PRL, as was our recombinant canine PRL.
In conclusion, this is the first report of the isolation and sequencing of full-length canine PRL cDNA. The deduced amino acid sequence was highly homologous to those of other species, including feline and porcine PRL. Moreover, recombinant canine prolactin was transiently expressed in mammalian cells and secreted into the medium as N-linked glycosylated (31 kDa) or nonglycosylated (27 kDa) proteins. We also found that the molecular weight of the recombinant protein was comparable to that of native PRL extracted from a dog pituitary. These findings should facilitate research into therapeutic targets for canine mammary tumors. To study the protein function of canine PRL, we are now generating cells stably expressing canine PRL.
